995 related articles for article (PubMed ID: 17253051)
1. Yellow fever as an endemic/epidemic disease and priorities for vaccination.
Monath TP
Bull Soc Pathol Exot; 2006 Dec; 99(5):341-7. PubMed ID: 17253051
[TBL] [Abstract][Full Text] [Related]
2. Prevention of yellow fever in persons traveling to the tropics.
Monath TP; Cetron MS
Clin Infect Dis; 2002 May; 34(10):1369-78. PubMed ID: 11981733
[TBL] [Abstract][Full Text] [Related]
3. Yellow fever in Africa: public health impact and prospects for control in the 21st century.
Tomori O
Biomedica; 2002 Jun; 22(2):178-210. PubMed ID: 12152484
[TBL] [Abstract][Full Text] [Related]
4. Yellow fever vaccines and international travelers.
Barnett ED; Wilder-Smith A; Wilson ME
Expert Rev Vaccines; 2008 Jul; 7(5):579-87. PubMed ID: 18564013
[TBL] [Abstract][Full Text] [Related]
5. Review of the risks and benefits of yellow fever vaccination including some new analyses.
Monath TP
Expert Rev Vaccines; 2012 Apr; 11(4):427-48. PubMed ID: 22551029
[TBL] [Abstract][Full Text] [Related]
6. [Modern features of epidemiology and prophylaxis of yellow fever].
Liashenko NI; Lukin EP
Voen Med Zh; 2010 Jun; 331(6):32-6. PubMed ID: 20731094
[TBL] [Abstract][Full Text] [Related]
7. [Yellow fever].
Wiercińska-Drapało A
Przegl Epidemiol; 2004; 58 Suppl 1():101-5. PubMed ID: 15807166
[TBL] [Abstract][Full Text] [Related]
8. Yellow fever: epidemiology and prevention.
Barnett ED
Clin Infect Dis; 2007 Mar; 44(6):850-6. PubMed ID: 17304460
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of vaccination against yellow fever of persons traveling to endemic areas].
Dabrowska MM; Flisiak R
Przegl Epidemiol; 2010; 64(2):319-22. PubMed ID: 20731245
[TBL] [Abstract][Full Text] [Related]
10. [Present status of an arbovirus infection: yellow fever, its natural history of hemorrhagic fever, Rift Valley fever].
Digoutte JP
Bull Soc Pathol Exot; 1999 Dec; 92(5):343-8. PubMed ID: 10690474
[TBL] [Abstract][Full Text] [Related]
11. [Yellow fever--a tropical danger].
Stingl P
MMW Fortschr Med; 2004 Aug; 146(31-32):36-7. PubMed ID: 15529706
[TBL] [Abstract][Full Text] [Related]
12. [Yellow fever vaccination: update on rare and severe adverse effects].
Receveur MC; Bruyand M; Pistone T; Malvy D
Med Mal Infect; 2009 Apr; 39(4):234-41. PubMed ID: 19167852
[TBL] [Abstract][Full Text] [Related]
13. Yellow fever vaccination in the Americas.
Bull Pan Am Health Organ; 1984; 18(2):188-92. PubMed ID: 6207882
[TBL] [Abstract][Full Text] [Related]
14. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].
da Silva A; Parent du Châtelet I; Beckr Gaye A; Dompnier JP; Seck I
Sante; 2003; 13(4):215-23. PubMed ID: 15047438
[TBL] [Abstract][Full Text] [Related]
15. Yellow fever in the Americas.
Bull Pan Am Health Organ; 1985; 19(2):209-12. PubMed ID: 4052698
[TBL] [Abstract][Full Text] [Related]
16. Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria.
Monath TP; Nasidi A
Am J Trop Med Hyg; 1993 Feb; 48(2):274-99. PubMed ID: 8447531
[TBL] [Abstract][Full Text] [Related]
17. [Reemergence of yellow fever in West Africa: lessons from the past, advocacy for a control program].
Moreau JP; Girault G; Dramé I; Perraut R
Bull Soc Pathol Exot; 1999 Dec; 92(5):333-6. PubMed ID: 10690471
[TBL] [Abstract][Full Text] [Related]
18. An inactivated cell-culture vaccine against yellow fever.
Monath TP; Fowler E; Johnson CT; Balser J; Morin MJ; Sisti M; Trent DW
N Engl J Med; 2011 Apr; 364(14):1326-33. PubMed ID: 21470010
[TBL] [Abstract][Full Text] [Related]
19. The enigma of yellow fever in East Africa.
Ellis BR; Barrett AD
Rev Med Virol; 2008; 18(5):331-46. PubMed ID: 18615782
[TBL] [Abstract][Full Text] [Related]
20. [Yellow fever epidemiology in Brazil].
Mondet B
Bull Soc Pathol Exot; 2001 Aug; 94(3):260-7. PubMed ID: 11681224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
